Lv1
40 积分 2024-02-23 加入
AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer
7天前
已完结
Developability Assessment During the Selection of Novel Therapeutic Antibodies
18天前
已完结
Human disease models in drug development
21天前
已完结
New approach methodologies: EU regulatory horizons
2个月前
已完结
Insights into new approach methodology innovation: an EMA perspective
2个月前
已完结
Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models
2个月前
已完结
Primary and secondary nonresponse to infliximab: mechanisms and countermeasures
2个月前
已完结
Crohn's disease
3个月前
已完结
The TL1A inhibitors in IBD: What’s in the pot?
4个月前
已完结
Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review
4个月前
已完结
皖公网安备34019202002308
